The US Food and Drug Administration revised the emergency use authorization for Pfizer's Covid-19 antiviral treatment, Paxlovid, on July 6 to allow state-licensed pharmacists to prescribe the treatment to people who are eligible.
Mandatory Credit: Philipp von Ditfurth/picture alliance/Getty Images
Stories this photo appears in:
FDA allows licensed pharmacists to prescribe Pfizer's Paxlovid under certain conditions
The US Food and Drug Administration revised the emergency use authorization for Pfizer's Covid-19 antiviral treatment, Paxlovid, on Wednesday to allow state-licensed pharmacists to prescribe the treatment to people who are eligible.
